To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom
Clinical trial NCT03368274 · UNKNOWN
Trial details
- NCT number
- NCT03368274
- Sponsor
- Wen Zhang
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2018-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.